Author

Melissa Cortes

Institution: Mayo Clinic in Florida

Observed institutions: Memorial Sloan Kettering Cancer Center, Mayo Clinic in Florida, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

OpenAlex ID: A5030998313

Outpatient BEAM Using Daily Etoposide and Cytarabine with Autologous Hematopoietic Stem Cell Transplantation for Lymphoma Is Feasible and Decreases Inpatient Length of Stay

2019 · Naomi Cazeau, Kathleen Cavalier, et al. · Blood · 7

A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma

2016 · Ajai Chari, Hearn Jay Cho, et al. · Blood · 4

Homebound Autologous Hematopoietic Cell Transplantation for Plasma Cell Disorders in an Urban Setting Is Safe for Patients and Preferred By Patients and Caregivers

2018 · Heather J. Landau, Gunjan L. Shah, et al. · Blood · 2

Feasibility of and Decreased Inpatient Hospital Days for Non-Hodgkin Lymphoma (NHL) and Hodgkin Lymphoma (HL) Patients with Outpatient BEAM Using Daily Etoposide and Cytarabine and Autologous Hematopoietic Stem Cell Transplantation (AHCT)

2020 · Kathleen Cavalier, Naomi Cazeau, et al. · Transplantation and Cellular Therapy · 1

Clostridium ramosum Bacteremia: Clinical Significance and Outcomes in a Multicenter Retrospective Cohort

2026 · Tatjana Gavrancic, Kassandra Stoddard, et al. · Research Square

Works count: 5

Citation count: 14

H-index: 2

I10-index: